Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modelo: CAS NO.53-19-0
Marca: Dm
State: Solid
Grade Standard: Medicine Grade
Volatile: Not Volatile
Certification: FDA
Paquete: Doble PE con bolsillo de aluminio
productividad: 500kg/month
transporte: Ocean,Air
Lugar de origen: Hebei, China
Apoyo sobre: 100kg/month
Certificados : ISO9001
Hafen: Shanghai,Shenzhen,Beijing
Tipo de Pago: L/C,T/T,Paypal
Incoterm: FOB,CIF
Produ Ct Nombre: Mitotan
Sinónimos: 4′-DDD; P'-DDD; CB-313; Peprin; Opeprim; lSodren; Mitotan; Mitotam; Lysodren; 2,4'-tde
Número de CAS: 53-19-0
Apariencia: polvo blanco
Ensayo: 98%+
ITEMS |
SPECIFICATION |
RESULTS |
Appearance (In house) |
White crystalline powder |
White crystalline powder |
Identification |
A: SPECTROSCOPIC IDENTIFICATION TESTS <197>, Infrared Spectroscopy: 197M(CN 1-May-2020) |
Conform |
|
B: The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. |
Conform |
Water |
≤0.5% |
0.01% |
Residue On Ignition |
≤0.5% |
0.15% |
Assay |
97.0%~103.0% on the anhydrous basis |
100.4% |
Packaging and Storage |
Preserve in tight, light-resistant containers. |
|
Conclusion: Conforms with USPNF 2021. |
Paquete: bolsa de educación doble con bolsa de aluminio o según lo requerido
Tiempo de entrega: stock
Puerto disponible: cualquier puerto en China
PRODUCTOS POR GRUPO : API e intermedios > APIS en polvo
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.